Literature DB >> 25419378

Microalbuminuria in untreated prehypertension and hypertension without diabetes.

Erhan Tenekecioglu1, Mustafa Yilmaz1, Osman Can Yontar1, Kemal Karaagac1, Fahriye Vatansever Agca1, Ahmet Tutuncu1, Mustafa Kuzeytemiz1, Adem Bekler2, Muhammed Senturk1, Ufuk Aydin3, Serafettin Demir4.   

Abstract

OBJECTIVE: Hypertension (HT) and prehypertension (preHT) were independent predictors of cardiovascular diseases. Urinary albumin leakage is a manifestation of generalized vascular damage. B-type natriuretic peptide (BNP) is a vasoactive peptide secreted by left ventricle in response to myocytic stretch. We aimed to investigate relationship between microalbuminuria (MA) and BNP in untreated elevated blood pressures.
METHODS: Of 105 untreated prehypertensive subjects (53 men, 52 women), 100 hypertensive subjects (51 men, 49 women) and 57 normotensive subjects (32 men, 25 women) none had history of diabetes. Urine albumin excretion was measured by immunoradiometric assay in morning urine sample.
RESULTS: The prevalence of MA was higher in hypertensive group than in prehypertensive group and in normotensive group (Hypertensive group; 33.9%, prehypertensive; 25.9%, normotensive; 10%). Subjects with HT had higher prevalence of microalbminuria; larger body mass index, higher levels of triglycerides, blood glucose and creatinin were more common in subjects with HT than in those with preHT. In hypertensive group; patients with microalbuminuria had higher systolic blood pressure (SBP), BNP, LVMI and lower eGFR as compared to those without MA. MA was significantly correlated with LVMI, BNP and SBP. In multivariate regression analysis, SBP (β: 0.361; P < 0.001), LVMII (β: 0.267; P = 0.011) and BNP (β: 0.284; P = 0.005) were independent variables associated with MA in hypertensives. In prehypertensive group; patients with microalbuminuria had higher SBP, BNP, LVMI and lower eGFR as compared to those without MA. MA was significantly correlated with LVMI, BNP and SBP. In multivariate regression analysis, SBP (β: 0.264; P = 0.002), LVMI (β: 0.293; P = 0.001) and BNP (β: 0.168; P = 0.045) were associated with MA in prehypertensives.
CONCLUSIONS: In preHT and HT, SBP, BNP and LVMI are associated with MA. In the evaluation of increased blood pressures, in case of increased BNP and LVMI, MA should be investigated even in prehypertensive stages. The subjects with increased blood pressures should get medical treatment to prevent the effects on vascular structure and myocardium even in prehypertensive phase.

Entities:  

Keywords:  Microalbuminuria; brain natriuretic peptide; hypertension; left ventricular mass; prehypertension

Year:  2014        PMID: 25419378      PMCID: PMC4238513     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  52 in total

1.  Variability in cholesterol measurements: comparison of calculated and direct LDL cholesterol determinations.

Authors:  G Schectman; M Patsches; E A Sasse
Journal:  Clin Chem       Date:  1996-05       Impact factor: 8.327

Review 2.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners.

Authors:  D Hörner; D Fliser; H P Klimm; E Ritz
Journal:  J Hypertens       Date:  1996-05       Impact factor: 4.844

Review 5.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

6.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

7.  Relation of albuminuria to left ventricular mass (from the HyperGEN Study).

Authors:  Luc Djoussé; Jinesh Kochar; Steven C Hunt; Kari E North; C Charles Gu; Weihong Tang; Donna K Arnett; Richard B Devereux
Journal:  Am J Cardiol       Date:  2008-01-15       Impact factor: 2.778

8.  Relationships between age, blood pressure, and retinal vessel diameters in an older population.

Authors:  Harry Leung; Jie Jin Wang; Elena Rochtchina; Ava G Tan; Tien Y Wong; Ronald Klein; Larry D Hubbard; Paul Mitchell
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-07       Impact factor: 4.799

9.  Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

Authors:  Torbjørn Omland; Marc S Sabatine; Kathleen A Jablonski; Madeline Murguia Rice; Judith Hsia; Ragnhild Wergeland; Sverre Landaas; Jean L Rouleau; Michael J Domanski; Christian Hall; Marc A Pfeffer; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2007-06-29       Impact factor: 24.094

10.  Role of prehypertension in the development of coronary atherosclerosis in Japan.

Authors:  Masakazu Washio; Shoji Tokunaga; Kouichi Yoshimasu; Hiroko Kodama; Ying Liu; Shizuka Sasazuki; Keitaro Tanaka; Suminori Kono; Masahiro Mohri; Akira Takeshita; Kikuo Arakawa; Munehito Ideishi; Takanobu Nii; Kazuyuki Shirai; Hidekazu Arai; Yoshitaka Doi; Tomoki Kawano; Osamu Nakagaki; Kazuyuki Takada; Koji Hiyamuta; Samon Koyanagi
Journal:  J Epidemiol       Date:  2004-03       Impact factor: 3.211

View more
  1 in total

1.  Proteinuria and risk of stroke in patients with hypertension: The Kailuan cohort study.

Authors:  Anxin Wang; Liye Dai; Zhaoping Su; Shuohua Chen; Junjuan Li; Shouling Wu; Yongjun Wang; Yilong Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-06       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.